Drug Profile
RAP 102
Alternative Names: KLH-RAP 101; RAP-102Latest Information Update: 27 Apr 2016
Price :
$50
*
At a glance
- Originator RAPID Pharmaceuticals
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 27 Apr 2016 No recent reports on development identified - Preclinical for HIV infections (Prevention) in USA (unspecified route)
- 29 Oct 2012 Preclinical development is ongoing in USA
- 30 Mar 2007 Preclinical trials in HIV infections (prevention) in USA (unspecified route)